Elissa Joy Charbonneau - 28 Feb 2026 Form 4 Insider Report for Encompass Health Corp (EHC)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Mar 2026, 12:14:00 UTC
Prior SEC filing
25 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Patrick Darby, attorney-in-fact for Ms. Charbonneau

Key filing fact

Elissa Joy Charbonneau filed Form 4 for Encompass Health Corp (EHC) on 03 Mar 2026.

Key facts

  • This page summarizes Elissa Joy Charbonneau's Form 4 filing for Encompass Health Corp (EHC).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Mar 2026, 12:14.

Change

  • Previous filing in this sequence was filed on 25 Feb 2026.
  • Current net transaction value: -$39,808.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001647458 Primary reporting owner

Charbonneau Elissa Joy

Relationship
Chief Medical Officer
Address
9001 LIBERTY PARKWAY, BIRMINGHAM
Signature
/s/ Patrick Darby, attorney-in-fact for Ms. Charbonneau
Signature date
03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EHC transaction

Encompass Health Common Stock

Tax liability

Transaction value
$39,808
Shares
-369
Change %
-2%
Price
$107.88
Shares after
17,644
Date
28 Feb 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .